Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How many disgruntled shareholders will be urging a chance of management here?

"I'm still pleased with the direction Goerner is taking PTSC and look forward to the 10K for updates."

Unless you have any insider information there is no evidence the direction of positioning PTSC as the company for datasharing and secure data solutions is the right direction for the company and its shareholders.

On the contrary, the shareprice today reflects a complete apathy towards the current transition story - the exitement Mr. Goerner was speaking of from the beginning (maybe you noted he stopped mentioning it since about more than eight, nine months) has not reached any new investors so far.

Thus I see no reason to be pleased with Mr. Goerner and the management.

GLTY

Share
New Message
Please login to post a reply